Aer Therapeutics

Enterprise Therapeutics

This biopharmaceutical company develops novel muco-regulatory therapies for patients with respiratory diseases including cystic fibrosis, asthma and chronic obstructive pulmonary disease.

Breath Therapeutics

This biopharmaceutical company develops inhaled drug-aerosol therapies for patients with bronchiolitis obliterans syndrome and other severe respiratory diseases.

AirNexis Therapeutics

This company develops inhaled small molecule medicines to treat chronic obstructive pulmonary disease for patients with respiratory conditions.

AirNexis

This clinical-stage biotechnology company develops inhaled therapies for patients with chronic obstructive pulmonary disease and other respiratory conditions.

Kither Biotech

This company develops inhaled therapies for patients with respiratory diseases such as chronic obstructive pulmonary disease and cystic fibrosis.

Elevation Pharmaceuticals

This biopharmaceutical company develops inhaled aerosol therapies for patients with chronic obstructive pulmonary disease to improve lung function and reduce treatment burden.

Kinaset Therapeutics

This biopharmaceutical company develops inhaled anti-inflammatory therapies to treat patients with severe asthma and other respiratory diseases.

Softhale

This company develops propellant-free soft mist inhaler devices and pharmaceutical products for patients suffering from asthma and chronic obstructive pulmonary disease.